Meyer J, Sive A, Jacobs P
University of Cape Town Leukaemia Centre, South Africa.
Acta Paediatr. 1993 Jan;82(1):30-4. doi: 10.1111/j.1651-2227.1993.tb12510.x.
In a prospective randomized trial, asymptomatic very low-birth-weight infants in a neonatal intensive care unit were either electively transfused with red cells to maintain capillary haematocrit greater than 0.35 l/1 (group 1; n = 9), or were not transfused (group 2; n = 10). Individuals from both groups were excluded if they subsequently received non-elective transfusions, necessitated by their clinical condition. Electively transfused infants gained weight more rapidly than their non-transfused counterparts, but the duration of hospitalization was not shortened. Criteria of morbidity, such as patent ductus murmurs, apnoea and failure to thrive, were similar in both groups. We conclude that in the absence of clinical indications, transfusion to achieve a hematocrit greater than 0.35 l/1 as an empiric procedure, improves weight gain but the risks of transfusion are likely to outweigh the benefits.
在一项前瞻性随机试验中,新生儿重症监护病房中无症状的极低出生体重儿被分为两组:一组(第1组,n = 9)接受红细胞选择性输血以维持毛细血管血细胞比容大于0.35 l/1,另一组(第2组,n = 10)不接受输血。如果两组中的个体随后因临床状况需要接受非选择性输血,则将其排除。选择性输血的婴儿体重增长比未输血的婴儿更快,但住院时间并未缩短。两组的发病率标准,如动脉导管杂音、呼吸暂停和发育不良等,相似。我们得出结论,在没有临床指征的情况下,作为一种经验性操作,输血使血细胞比容大于0.35 l/1可改善体重增加,但输血风险可能超过益处。